Cooper Companies Inc
COO82.750USD
+0.290+0.35%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
16.21BCap. mercado
43.95P/E TTM
Más Datos de Cooper Companies Inc Compañía
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Información de Cooper Companies Inc
Símbolo de cotizaciónCOO
Nombre de la empresaCooper Companies Inc
Fecha de salida a bolsaJan 21, 1983
Director ejecutivoWhite (Albert G)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 21
Dirección6101 Bollinger Canyon Road
CiudadSAN RAMON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94583
Teléfono19254603600
Sitio Webhttps://www.coopercos.com/
Símbolo de cotizaciónCOO
Fecha de salida a bolsaJan 21, 1983
Director ejecutivoWhite (Albert G)
Ejecutivos de Cooper Companies Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
7.66K
+55.08%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+15.72%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
5.78K
+52.95%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+320.67%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
516.20M
48.68%
Europe
343.10M
32.36%
Rest of the World
201.00M
18.96%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Otro
68.01%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Otro
68.01%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
58.31%
Investment Advisor/Hedge Fund
34.98%
Hedge Fund
6.21%
Research Firm
3.96%
Bank and Trust
1.29%
Pension Fund
1.27%
Family Office
0.91%
Family Office
0.91%
Family Office
0.70%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1362
208.96M
111.56%
-3.88K
2025Q3
1410
208.99M
111.74%
+4.12M
2025Q2
1399
205.52M
107.52%
+1.81M
2025Q1
1380
203.24M
103.36%
-3.45M
2024Q4
1357
199.65M
102.09%
+3.47M
2024Q3
1324
195.11M
102.83%
-1.38M
2024Q2
1308
196.62M
100.46%
+4.01M
2024Q1
1307
191.91M
103.85%
-14.49M
2023Q4
1291
198.78M
104.05%
+1.21M
2023Q3
1279
197.30M
102.69%
+609.87K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
24.16M
12.15%
+419.27K
+1.77%
Jun 30, 2025
Capital World Investors
8.39M
4.22%
+645.79K
+8.34%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.76M
4.91%
-120.78K
-1.22%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.38M
3.71%
+106.52K
+1.46%
Jun 30, 2025
State Street Investment Management (US)
8.66M
4.36%
+104.91K
+1.23%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
7.85M
3.95%
-130.44K
-1.63%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.21M
2.62%
+127.91K
+2.52%
Jun 30, 2025
Sustainable Growth Advisers, LP
3.39M
1.7%
+2.79M
+466.43%
Jun 30, 2025
Neuberger Berman, LLC
5.06M
2.55%
+1.46M
+40.32%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
First Trust Indxx Medical Devices ETF
2.05%
Themes US R&D Champions ETF
1.96%
Invesco Bloomberg Pricing Power ETF
1.89%
State Street SPDR S&P Health Care Equipment ETF
1.85%
Invesco S&P 500 Equal Weight Health Care ETF
1.69%
Motley Fool Mid-Cap Growth ETF
1.59%
Congress SMid Growth ETF
1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
1.19%
Pacer US Export Leaders ETF
0.95%
First Trust Health Care Alphadex Fund
0.89%
Ver más
First Trust Indxx Medical Devices ETF
Proporción2.05%
Themes US R&D Champions ETF
Proporción1.96%
Invesco Bloomberg Pricing Power ETF
Proporción1.89%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.85%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.69%
Motley Fool Mid-Cap Growth ETF
Proporción1.59%
Congress SMid Growth ETF
Proporción1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
Proporción1.19%
Pacer US Export Leaders ETF
Proporción0.95%
First Trust Health Care Alphadex Fund
Proporción0.89%
Dividendos
Un total de
9.00M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020
División de acciones
Fecha
Tipo
Relación
Dec 07, 2023
Split
1→4
Fecha
Tipo
Relación
Dec 07, 2023
Split
1→4
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cooper Companies Inc?
Los cinco principales accionistas de Cooper Companies Inc son:
The Vanguard Group, Inc. posee 24.16M acciones, lo que representa el 12.15% del total de acciones.
Capital World Investors posee 8.39M acciones, lo que representa el 4.22% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 9.76M acciones, lo que representa el 4.91% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 7.38M acciones, lo que representa el 3.71% del total de acciones.
State Street Investment Management (US) posee 8.66M acciones, lo que representa el 4.36% del total de acciones.
The Vanguard Group, Inc. posee 24.16M acciones, lo que representa el 12.15% del total de acciones.
Capital World Investors posee 8.39M acciones, lo que representa el 4.22% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 9.76M acciones, lo que representa el 4.91% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 7.38M acciones, lo que representa el 3.71% del total de acciones.
State Street Investment Management (US) posee 8.66M acciones, lo que representa el 4.36% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Cooper Companies Inc?
Los tres principales tipos de accionista de Cooper Companies Inc son:
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.
¿Cuántas instituciones poseen acciones de Cooper Companies Inc (COO)?
A fecha de 2025Q4, 1362 instituciones poseen acciones de Cooper Companies Inc, con un valor de mercado combinado de aproximadamente 208.96M, lo que representa el 111.56% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.18%.
¿Cuál es la mayor fuente de ganancias de Cooper Companies Inc?
El FY2025Q3, el segmento empresarial Sphere, other generó la ganancia más alta para Cooper Companies Inc, ascendiendo a 359.60M y representando el 33.91% de la ganancia total.
